Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Frew

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
JAMA Dermatology|August 9, 2013
Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaireDeshan F Sebaratnam, Anna Marie Hanna, Shien-ning Chee, et al.
Pain and Therapy|October 17, 2025
Bimekizumab Pain Outcomes in Patients with Hidradenitis Suppurativa: Pooled 48-Week Results from BE HEARD I&II Phase 3 Randomized Clinical TrialsJohn R Ingram, Hideki Fujita, Alice B Gottlieb, et al.
The British Journal of Dermatology|November 17, 2023
Global consensus process to establish a core dataset for hidradenitis suppurativa registriesHannah E Wainman, Nisha S Chandran, John W Frew, et al.
The Journal of Experimental Medicine|May 21, 2026
CSF1R-dependent CD169-positive macrophages locally constrain melanoma growth in the skinYuki Honda Keith, Emily Duchini, Xufeng Lin, et al.
Dermatology and Therapy|May 23, 2026
Criteria for Hidradenitis Suppurativa Competence CentersAngelo V Marzano, Falk G Bechara, Vivian Y Shi, et al.
Experimental Dermatology|November 29, 2018
Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017Eran Shavit, Afsaneh Alavi, Falk G Bechara, et al.
The Journal of Investigative Dermatology|June 20, 2024
Standardized Protocols for Clinical and Histopathological Characterization of Hidradenitis Suppurativa Tissue SpecimensAshwath Jonathan Sampath, Linnea L Westerkam, Franklin R Blum, et al.
Experimental Dermatology|October 15, 2020
What causes hidradenitis suppurativa ?-15 years afterChristos C Zouboulis, Farida Benhadou, Angel S Byrd, et al.
JAMA Dermatology|November 26, 2025
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa: A Consensus Exercise Using a Modified Delphi ApproachAmit Garg, Andrew Strunk, Bria Midgette, et al.
The British Journal of Dermatology|March 5, 2026
Evaluating the diagnostic accuracy of a screening questionnaire for detecting hidradenitis suppurativa: a pooled analysis of accuracy measures from the Global Hidradenitis Suppurativa Atlas (GHiSA) studyDorra Bouazzi, Søren Lophaven, Paa Gyasi Hagan, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
JAMA Dermatology|August 9, 2013
Development of a quality-of-life instrument for autoimmune bullous disease: the Autoimmune Bullous Disease Quality of Life questionnaireDeshan F Sebaratnam, Anna Marie Hanna, Shien-ning Chee, et al.
Pain and Therapy|October 17, 2025
Bimekizumab Pain Outcomes in Patients with Hidradenitis Suppurativa: Pooled 48-Week Results from BE HEARD I&II Phase 3 Randomized Clinical TrialsJohn R Ingram, Hideki Fujita, Alice B Gottlieb, et al.
The British Journal of Dermatology|November 17, 2023
Global consensus process to establish a core dataset for hidradenitis suppurativa registriesHannah E Wainman, Nisha S Chandran, John W Frew, et al.
The Journal of Experimental Medicine|May 21, 2026
CSF1R-dependent CD169-positive macrophages locally constrain melanoma growth in the skinYuki Honda Keith, Emily Duchini, Xufeng Lin, et al.
Dermatology and Therapy|May 23, 2026
Criteria for Hidradenitis Suppurativa Competence CentersAngelo V Marzano, Falk G Bechara, Vivian Y Shi, et al.
Experimental Dermatology|November 29, 2018
Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017Eran Shavit, Afsaneh Alavi, Falk G Bechara, et al.
The Journal of Investigative Dermatology|June 20, 2024
Standardized Protocols for Clinical and Histopathological Characterization of Hidradenitis Suppurativa Tissue SpecimensAshwath Jonathan Sampath, Linnea L Westerkam, Franklin R Blum, et al.
Experimental Dermatology|October 15, 2020
What causes hidradenitis suppurativa ?-15 years afterChristos C Zouboulis, Farida Benhadou, Angel S Byrd, et al.
JAMA Dermatology|November 26, 2025
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa: A Consensus Exercise Using a Modified Delphi ApproachAmit Garg, Andrew Strunk, Bria Midgette, et al.
The British Journal of Dermatology|March 5, 2026
Evaluating the diagnostic accuracy of a screening questionnaire for detecting hidradenitis suppurativa: a pooled analysis of accuracy measures from the Global Hidradenitis Suppurativa Atlas (GHiSA) studyDorra Bouazzi, Søren Lophaven, Paa Gyasi Hagan, et al.
Pageof 10